Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538122 · ClinicalTrials.gov registry record
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 12
- Enrollment target
NCT00538122: Completed study, sponsored by Vanderbilt University.
NCT00538122 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00538122 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This study is being done to look at the electrical activity of the heart. This study will help decide whether taking recordings for a 24-hour period gives more useful information than recording it for a few seconds in a doctor's office. The study will compare 24 hour electrocardiogram (ECG) results of patients taking thioridazine (Mellaril) to those of other patients taking different medications that took part in another study.
Interventions
- DEVICE 24 Holter Monitor Recording
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-09 |
What the finished NCT00538122 record still lists
NCT00538122 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 24 Holter Monitor Recording is the first listed.
NCT00538122 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00538122 about?
NCT00538122 is a clinical study titled "Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment". This study is being done to look at the electrical activity of the heart. This study will help decide whether taking recordings for a 24-hour period gives more useful information than recording it for a few seconds in a doctor's office. The study will compare 24 hour electrocardiogram (ECG) results ...
What is the current status of trial NCT00538122?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2007-07. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00538122?
The interventions under investigation include: 24 Holter Monitor Recording (DEVICE).
Who is sponsoring clinical trial NCT00538122?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia